Related Content
- Communiqué: Warfarin: Genotyping and Improving Dosing
- Communiqué: How to Interpret and Pursue an Abnormal Prothrombin Time, Activated Partial Thromboplastin Time, and Bleeding Time in Adults
- Communiqué: Importance of Device Evaluation for Point-of-Care Prothrombin Time International Normalized Ratio Testing Programs
- Communiqué: The Diagnosis and Treatment of Hypercoagulability States
- Hot Topic: Warfarin Sensitivity Genotyping
- Hot Topic: Paroxysmal Nocturnal Hemoglobinuria
- Hot Topic: Guidelines for Anticoagulation Therapy for Secondary Prevention After Deep Vein Thrombosis
External
link
PDF
document
Excel
document
Word
document